Gastroenterology
Famotidine PSK
Registration certificate:
INN:
Famotidine
Release form:
Lyophilisate for the preparation of a solution for intravenous injection
Therapeutic Area:
Gastroenterology
Pharmacotherapeutic Group:
Gastric secretion inhibitor – H2-histamine receptor blocker
Conditions for dispensing:
On prescription
Packaging:

Indications for use:

Famotidine is indicated for the treatment of:

  • Duodenal ulcer;
  • Benign gastric ulcer;
  • Gastroesophageal reflux disease (GERD);
  • Conditions associated with hypersecretion of gastric acid (e.g., Zollinger-Ellison syndrome);
  • Prevention of acid aspiration (Mendelson's syndrome) during general anesthesia.

This product is included in the Essential Drug List (EDL).

Regulatory Status: Rx only 

THERE ARE CONTRAINDICATIONS AND DRUG INTERACTIONS. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the medical use instructions for Famotidine PSK (Famotidine), lyophilisate for solution for intravenous injection, 20 mg, please visit the official website: grls.rosminzdrav.ru (https://grls.rosminzdrav.ru/Default.aspx)


Quality control
at all stages of production